Samsung Pharm (001360) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.013x

Based on the latest financial reports, Samsung Pharm (001360) has a cash flow conversion efficiency ratio of -0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.29 Billion ≈ $-1.55 Million USD) by net assets (₩180.09 Billion ≈ $122.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Samsung Pharm balance sheet independence to measure how much of total assets are equity-financed.

Samsung Pharm - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Samsung Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Samsung Pharm cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Samsung Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Samsung Pharm ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
AMCON Distributing Company NYSE MKT:DIT	0.122x
AGF A/S CO:AGF-B	-0.067x
DeFi Development Corp. NASDAQ:DFDV	-0.963x
ST Dupont PA:DPT	-0.078x
Osmanli Menkul Degerler AS IS:OSMEN	-0.129x
RGB International Bhd KLSE:0037	0.068x
Blue Cap AG XETRA:B7E	0.124x
Radhika Jeweltech Limited NSE:RADHIKAJWE	0.003x

Annual Cash Flow Conversion Efficiency for Samsung Pharm (2012–2024)

The table below shows the annual cash flow conversion efficiency of Samsung Pharm from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 001360 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩105.86 Billion ≈ $71.74 Million	₩-17.30 Billion ≈ $-11.72 Million	-0.163x	+54.17%
2023-12-31	₩77.58 Billion ≈ $52.58 Million	₩-27.66 Billion ≈ $-18.74 Million	-0.356x	-1810.44%
2022-12-31	₩102.59 Billion ≈ $69.52 Million	₩-1.91 Billion ≈ $-1.30 Million	-0.019x	+66.85%
2021-12-31	₩127.27 Billion ≈ $86.25 Million	₩-7.16 Billion ≈ $-4.85 Million	-0.056x	-168.73%
2020-12-31	₩121.92 Billion ≈ $82.62 Million	₩-2.55 Billion ≈ $-1.73 Million	-0.021x	-22.88%
2019-12-31	₩142.83 Billion ≈ $96.79 Million	₩-2.43 Billion ≈ $-1.65 Million	-0.017x	+65.59%
2018-12-31	₩131.66 Billion ≈ $89.23 Million	₩-6.52 Billion ≈ $-4.42 Million	-0.050x	-190.23%
2017-12-31	₩93.87 Billion ≈ $63.61 Million	₩5.15 Billion ≈ $3.49 Million	0.055x	+145.48%
2016-12-31	₩82.38 Billion ≈ $55.83 Million	₩-9.94 Billion ≈ $-6.74 Million	-0.121x	-32.70%
2015-12-31	₩46.24 Billion ≈ $31.33 Million	₩-4.20 Billion ≈ $-2.85 Million	-0.091x	+84.40%
2014-12-31	₩23.29 Billion ≈ $15.79 Million	₩-13.58 Billion ≈ $-9.21 Million	-0.583x	-81.92%
2012-12-31	₩34.71 Billion ≈ $23.52 Million	₩-11.13 Billion ≈ $-7.54 Million	-0.321x	--

About Samsung Pharm

KO:001360 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$81.26 Million

₩119.91 Billion KRW

Market Cap Rank

#19929 Global

#1009 in Korea

Share Price

₩1274.00

Change (1 day)

-3.04%

52-Week Range

₩1243.00 - ₩2210.00

All Time High

₩12289.83